Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.8350
-0.0010 (-0.12%)
At close: Sep 12, 2025, 4:00 PM EDT
0.8390
+0.0040 (0.48%)
Pre-market: Sep 15, 2025, 7:17 AM EDT

Context Therapeutics Stock Forecast

CNTX's stock price has decreased by -60.98% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 4 analysts that cover Context Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $5.25, which forecasts a 528.74% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $9.00.

Price Target: $5.25 (+528.74%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$4.00$5.25$4.00$9.00
Change+379.04%+528.74%+379.04%+977.84%
* Price targets were last updated on Aug 7, 2025.

Analyst Ratings

The average analyst rating for Context Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy332222
Buy333333
Hold000000
Sell000000
Strong Sell000000
Total665555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$9
Strong BuyMaintains$9+977.84%Aug 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$5$4
Strong BuyMaintains$5$4+379.04%Aug 7, 2025
Piper Sandler
Piper Sandler
Buy
Reiterates
$4.5$4
BuyReiterates$4.5$4+379.04%Jun 26, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$9
Strong BuyMaintains$9+977.84%May 8, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$9
Strong BuyMaintains$9+977.84%Apr 29, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.33
from -0.46
EPS Next Year
-0.43
from -0.33
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-------
Revenue Growth
-------
EPS
-3.96-3.69-0.93-1.50-0.46-0.33-0.43
EPS Growth
-------
Forward PE
-------
No. Analysts
-----88
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-0.28-0.23
Avg-0.33-0.43
Low-0.39-0.70

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.